GPT and Hyperbilirubinemia: Grade 3/4 adverse drug reactions: 82% [78–86]  Grade 3/4 hyperbilirubinemia: 5% [1–15] (2/43)  Grade 3/4 lipase: 0%  Grade 3/4 ALT: 0.6%